Free Trial
NASDAQ:AEZS

Aeterna Zentaris (AEZS) Stock Price, News & Analysis

Aeterna Zentaris logo
$4.10 +0.26 (+6.77%)
As of 07/17/2025

About Aeterna Zentaris Stock (NASDAQ:AEZS)

Key Stats

Today's Range
$3.64
$4.10
50-Day Range
$3.30
$4.10
52-Week Range
$3.96
$12.00
Volume
19,807 shs
Average Volume
7,305 shs
Market Capitalization
$7.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AEZS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aeterna Zentaris and its competitors with MarketBeat's FREE daily newsletter.

AEZS Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
CSCI:CA COSCIENS Biopharma Inc.
Chimerix Inc (CXF.BE)
See More Headlines

AEZS Stock Analysis - Frequently Asked Questions

Aeterna Zentaris' stock was trading at $2.77 at the beginning of the year. Since then, AEZS shares have increased by 48.0% and is now trading at $4.10.

Aeterna Zentaris Inc. (NASDAQ:AEZS) released its earnings results on Thursday, November, 4th. The biopharmaceutical company reported ($1.00) earnings per share for the quarter, topping the consensus estimate of ($2.00) by $1.00. The biopharmaceutical company had revenue of $0.60 million for the quarter, compared to analysts' expectations of $0.60 million. Aeterna Zentaris had a negative net margin of 760.32% and a negative trailing twelve-month return on equity of 83.45%.

Shares of Aeterna Zentaris reverse split on the morning of Friday, May 3rd 2024.The 1-4 reverse split was announced on Friday, May 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Shares of AEZS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aeterna Zentaris investors own include Tonix Pharmaceuticals (TNXP), Bausch Health Cos (BHC), Ford Motor (F), DarioHealth (DRIO), Acasti Pharma (ACST), Onconova Therapeutics (ONTX) and Meta Platforms (META).

Company Calendar

Last Earnings
11/04/2021
Today
7/18/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AEZS
CIK
1113423
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($14.86)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.55 million
Net Margins
-760.32%
Pretax Margin
-760.28%
Return on Equity
-83.45%
Return on Assets
-45.76%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.94
Quick Ratio
5.93

Sales & Book Value

Annual Sales
$2.37 million
Price / Sales
2.73
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$14.99 per share
Price / Book
0.24

Miscellaneous

Outstanding Shares
1,793,000
Free Float
1,791,000
Market Cap
$6.49 million
Optionable
No Data
Beta
1.55

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:AEZS) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners